Yuji Yamamoto
- Hepatology top 2%
- Ophthalmology top 2%
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment 17
-
- Gastric Cancer Management and Outcomes 30
- Metastasis and carcinoma case studies 17
- Cerebrovascular and Carotid Artery Diseases 13
- Pharmacology top 2%
-
- Intracranial Aneurysms: Treatment and Complications 24
- Traumatic Brain Injury and Neurovascular Disturbances 16
- Vascular Malformations Diagnosis and Treatment 12
-
- Esophageal and GI Pathology 11
- Co-authors
- Akihiko TsuruokaYasuhiro FunahashiJunji MatsuiToshiaki WAKABAYASHIMakoto AsadaToshimitsu UenakaTatsuo WatanabeNaoko Hata Sugi
- Journals
- New England Journal of Medicine (1 paper)Nature Communications (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Yuji Yamamoto
219 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Hepatology 405
- Ophthalmology 271
- Gastroenterology 142
- Pulmonary and Respiratory Medicine 845
- Pharmacology 225
Countries citing papers authored by Yuji Yamamoto
This map shows the geographic impact of Yuji Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Yamamoto more than expected).
Fields of papers citing papers by Yuji Yamamoto
This network shows the impact of papers produced by Yuji Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Yamamoto. The network helps show where Yuji Yamamoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuji Yamamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2021 | 6 | |
| 3 | 2020 | 12 | |
| 4 | 2018 | 0 | |
| 5 | 2018 | 36 | |
| 6 | 2009 | 2 | |
| 7 | 2006 | 0 | |
| 8 | E7080, an oral multitargeted tyrosine kinase inhibitor, has direct anti-tumor efficacy via inhibition of KIT signaling in gastrointestinal stromal tumor (GIST) | 2006 | 2 |
| 9 | 2005 | 0 | |
| 10 | 2001 | 5 | |
| 11 | Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity. | 2000 | 188 |
| 12 | 1992 | 0 | |
| 13 | [Enhanced effect of intraperitoneal administration of CDDP combined with caffeine against peritoneal metastasis]. | 1991 | 1 |
| 14 | 1991 | 4 | |
| 15 | 1990 | 1 | |
| 16 | 1989 | 0 | |
| 17 | 1987 | 2 | |
| 18 | Traumatic acute intracerebellar hematoma. Especially the value of CT follow up | 1983 | 2 |
| 19 | Massive hemorrhage in tumor of tuberous sclerosis. | 1977 | 43 |
| 20 | Doppler examination of blood flow in the ocular fundus. | 1975 | 3 |
About Yuji Yamamoto
Yuji Yamamoto is a scholar working on Gastroenterology, Neurology and Pulmonary and Respiratory Medicine, having authored 244 papers that have together received 3.4k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (30 papers), Intracranial Aneurysms: Treatment and Complications (24 papers), Gastrointestinal Tumor Research and Treatment (17 papers), Metastasis and carcinoma case studies (17 papers), Traumatic Brain Injury and Neurovascular Disturbances (16 papers), Cerebrovascular and Carotid Artery Diseases (13 papers), Vascular Malformations Diagnosis and Treatment (12 papers) and Esophageal and GI Pathology (11 papers). The work is most often cited by research in Hepatology (405 citations), Ophthalmology (271 citations) and Gastroenterology (142 citations). Yuji Yamamoto has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Akihiko Tsuruoka, Yasuhiro Funahashi, Junji Matsui, Toshiaki WAKABAYASHI, Makoto Asada, Toshimitsu Uenaka, Tatsuo Watanabe, Naoko Hata Sugi, Motohira Yoshida and Shoji Asari. Their work appears in journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.